SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy -- Ignore unavailable to you. Want to Upgrade?


To: Jim Oravetz who wrote (147)7/29/1999 7:13:00 AM
From: Jim Oravetz  Read Replies (1) | Respond to of 370
 
DJ Vion Pharma Files To Offer 3.6M Common Shares
7/27/99
WASHINGTON (Dow Jones)--Vion Pharmaceuticals Inc. (VION) filed to offer 3.6 million common shares.
In a filing Tuesday with the Securities and Exchange Commission, the company said proceeds from the offering will be used for working capital, including for product research and development, marketing and other general purposes.
Bean Murray & Co. Inc. will underwrite the offering, which has an overallotment opiton of up to an additional 540,000 shares.
jim